Work

EP1.04-23 Ongoing Phase II Trial of Anti-PD1 Therapy in Combination with CIMAvax-EGF in Patients with Advanced NSCLC or Squamous Cell Head and Neck Cancer

Year: 2019

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.2126

Authors: G. Dy, T. Crombet, K. Leon, Z. Mazzora, D. Hernandez, A. Lage, A. Dozier, H. Chen, A. Hutson, D. Plessinger, C. Johnson

Institutions: Roswell Park Comprehensive Cancer Center, Center of Molecular Immunology (Cuba)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2981451798

FWCI: 0.182

Cites:

Cited by: 4

Related to: 10